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Abstract
An efficient Ugi three-component reaction of a preformed chiral ketimine derived from isatin with various isonitrile and acid
components has been developed. The reactions proceeded smoothly and in a stereocontrolled manner with regard to the new center
of the Ugi products due to the stereoinduction of the amine chiral residue. A wide variety of novel chiral 3,3-disubstituted
3-aminooxindoles were obtained, a selection of which were subjected to post-Ugi transformations, paving the way to application as
peptidomimetics.
Introduction
Isatin and its derivatives have drawn considerable and renewed
interest due to their peculiar chemistry and wide range of bioac-
tivities. This led to the development of stereoselective method-
ologies and the synthesis of compounds with various biological
properties [1]. In particular, the high reactivity of the C-3
prochiral carbonyl group allows the easy transformation of
isatin into 2-oxindole derivatives, mostly by nucleophilic addi-
tions or spiroannulation [2,3]. Oxindoles represent a common
structural element in various natural products and biologically
active compounds. Diverse oxindole derivatives act as non-
peptide scaffolds [4] in peptidomimetic chemistry, either as
enzyme inhibitors or as ligands of G-protein-coupled receptors
[5]. In particular, 3,3-disubstituted 3-amino-2-oxindoles are
present in several drug candidates. They exhibit various types of
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Figure 1: Biologically active agents containing a 3-substituted-3-aminooxindole core.
bioactivity, such as the potent gastrin/CCK-B receptor antago-
nist I [6], the vasopressin VIb receptor antagonist II [7,8], the
CRTH2 (DP2) receptor antagonist spirohydantoin III [9], and
the new antimalarial lead IV [10,11] (Figure 1).
Giving the importance of this structural motif, the development
of rapid synthetic methods for oxindoles bearing a nitrogen
atom at the C3-stereogenic center is highly required [12-15]. In
the course of our studies on new methodologies to access chiral
3,3-disubstituted 3-aminooxindoles [16-19], we looked at
isocyanide-based multicomponent reactions as a possible effi-
cient tool to quickly prepare oxindole-based peptidomimetic
compounds [20-22]. Despite the synthetic efficiency of the Ugi
reaction and its wide application in combinatorial and medic-
inal chemistry [23-28], to the best of our knowledge a synthesis
of 3,3-disubstituted 3-aminooxindoles which relies on
isocyanide-based multicomponent reactions has not been unex-
plored yet.
Although in this kind of reaction a new stereogenic center is
created, the stereoselectivity remains a difficult task. Waiting
for enantioselective versions of the Ugi reaction [29-31], the
diastereoselective approach by using chiral material is a
possible solution. In particular, amines have shown to be
promising as chiral auxiliaries, even though only a few exam-
ples with satisfactory selectivity were achieved to date [32-36].
Results and Discussion
Relying on our previous experience, we selected chiral ketimine
1 as a suitable substrate and started to investigate the Ugi three-
component reaction (3CR) with tert-butyl isocyanide (2a) and
trifluoroacetic acid (TFA, 3a) under various reaction conditions.
Compound 1 was easily prepared by treatment of isatin with
(S)-phenyl ethylamine in the presence of MgSO4 [16]. The
results of this initial study are reported in Table 1.
Running the reaction in 2,2,2-trifluoroethanol for 4 days
produced only a complex mixture (Table 1, entry 1), while the
use of dichloromethane as a solvent allowed us to obtain the
desired Ugi product 4 under various reagents ratio albeit in
moderate yields and low dr (Table 1, entries 2–5). A change of
the solvent to methanol resulted in a pronounced improvement
of the reaction. The reaction of imine 1 with 2 equiv of both
isocyanide and TFA in methanol (Table 1, entry 7) afforded the
product 4 in 77% yield and 89:11 dr after 48 hours at room
temperature. A variation of the concentration of 1 in the range
from 0.05 M to 0.2 M did not entail any modification, neither in
terms of yield nor dr. The remaining imine and a small amount
of isatin could be detected from a 1H NMR analysis of the
crude. The presence of either excess of 3a (Table 1, entry 6) or
additives (Table 1, entry 8 and entry 9) did not affect the results
significantly. Surprisingly, the yield decreased upon adding
MgBr2, even though this promoter was shown to perform well
in other reactions on ketimine 1. Evidently, in this case, the
effective protonation of the nitrogen would be required in order
to efficiently carry out the attack of the moderately nucle-
ophilic isonitrile. An increase of the reaction temperature (Ta-
ble 1, entry 10) facilitated a slightly shorter reaction time. Based
on this result, we decided to investigate the use of microwave
irradiation, with the aim of further increasing the speed of the
reaction. Running the reaction in methanol under microwave ir-
radiation (300 W) at 65 °C afforded the product after 3 min,
with a yield and a dr almost comparable to that obtained under
conventional heating conditions (Table 1, entry 11). An increase
of the temperature to 100 °C (Table 1, entry 12) or carrying out
the reaction in the absence of a solvent (Table 1, entry 13) led to
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Table 1: Optimization of reaction conditions for the U-3CR of 1 with tert-butyl isocyanide and TFA.
entry solvent time 1 (0.1 M):2a:3a temp. yielda dr (a:b)b
1 TFE 4 d 1:2:2 rt complex mixture –
2 CH2Cl2 4 d 1:2:2 rt 29 57:43
3 CH2Cl2 4 d 1:2:3 rt 38 62:38
4 CH2Cl2 4 d 1:3:3 rt 32 60:40
5 CH2Cl2 6 d 1:2:3 rt 50 60:40
6 MeOH 4 d 1:2:3 rt 65 85:15
7 MeOH 48 h 1:2:2 rt 77c 89:11c
8d MeOH 48 h 1:2:2 rt 73 81:19
9e MeOH 48 h 1:2:2 rt 53c 90:10c
10 MeOH 36 h 1:2:2 65 °C 67 85:15
11f MeOH 3 min 1:2:2 65 °C 69 87:13
12f MeOH 3 min 1:2:2 100 °C 67 71:29
13f neat 3 min 1:2:2 65 °C 37 60:40
14g MeOH 6 h 1:2:2 rt 54 89:11
aIsolated yield (%) after chromatographic purification (sum of the two diastereoisomers a (major) and b (minor)). bdr as determined by 1H NMR
analysis of the crude. cAverage value resulting from two runs. dLiCl (1 equiv) was added. eMgBr2 (1 equiv) was added. fUnder microwave irradiation
(300 W). gUnder sonication.
a reduction of both the yield and the reaction rate. The applica-
tion of sonication to shorten the reaction times was also useful,
since compound 4 was obtained after 6 hours with the same dr,
although in a lower yield (Table 1, entry 14).
To exploit the potential of the Ugi reaction to introduce molec-
ular diversity by a one-pot operation, we attempted to realize a
four-component (4CR) version. An equimolar mixture of isatin
and (S)-phenyl ethylamine was reacted with 2a (2 equiv) and 3a
(2 equiv) in methanol in the presence of MgSO4 as a dehy-
drating agent to promote the formation of the ketimine. Unfor-
tunately, after 4 days, the Ugi product was only afforded in very
low yield.
In order to explain the observed diastereoselectivity, the major
diastereoisomer 4a, easily separated from the minor diastereo-
isomers 4b by column chromatography, was crystallized from a
1:1 acetone/water solution.
The X-ray diffraction of the obtained crystal established the
absolute configuration S at the tetrasubstituted stereocenter C3,
which corresponds to C7a of the arbitrary atom-numbering
scheme used (Figure 2). The stereochemical assignment S was
attributed on the basis of the known (S)-configuration of the
phenyl ethylamine residue.
Figure 2: ORTEP [37] view of one of the two independent molecules
of 4a present in the asymmetric unit, showing the arbitrary atom-
labelling scheme. Atomic displacement parameters for non-H atoms
are at a probability level of 50%.
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Figure 3: Proposed explanation of the stereochemical outcome of the Ugi 3CR.
Table 2: Reaction of imine 1 with different isocyanide and acid components.a
entry 2 (R1) 3 (R2CO2H) yieldb dr (a:b)c compd
1 2a (t-Bu) 3a (TFA) 77 89:11 4a,b
2 2a (t-Bu) 3b (HCO2H) 62 63:37 5a,b
3 2b (CH2CO2Me) 3a (TFA) 70 88:12 6a,b
4 2b (CH2CO2Me) 3b (HCO2H) 66 70:30 7a,b
5 2c (Bn) 3a (TFA) 66 65:35 8a,b
6 2c (Bn) 3b (HCO2H) 70 64:36 9a,b
7 2d [C(CH3)2CH2(CH3)3] 3b (HCO2H) 48 69:31 10a,b
8 2a (t-Bu) 3c (N-Boc-L-Ala-OH) 51 62:38 11a,b
9 2a (t-Bu) 3d (N-Boc-L-Pro-OH) 31 77:23 12a,b
10 2a (t-Bu) 3e (N-Boc-D-Pro-OH) 18 96:4 13a,b
11 2a (t-Bu) 3f (N-Ac-Gly-OH) complex mixt. –
12 2a (t-Bu) 3g (mono-ethyl fumarate) 74 62:38 14a,b
13 2c (Bn) 3g (mono-ethyl fumarate) 47 59:41 15a,b
aReaction conditions: 1 (0.1 M), 2 (2 equiv), 3 (2 equiv), MeOH, rt, 48 h. bIsolated yield (%) after chromatographic purification (sum of the two dia-
stereoisomers a (major) and b (minor)). cdr as determined by 1H NMR analysis of the crude.
This outcome corroborated our previous achievements on add-
ition reactions to ketimine 1. Figure 3 shows a working model
able to explain the observed diastereoselectivity (R1 = t-Bu, R2
= CF3). The stereochemical outcome can be justified by the
presence of the 1,3-allylic strain, which favors the con-
formation on the right side of Figure 3. The major diastereoiso-
mer originates from the prevailing delivery of the nucleophile
from the less hindered re face of the imine double bond.
Aimed to investigate the synthetic scope and limitations of our
approach, we finally choose the reaction conditions reported in
Table 1, entry 7 as the most convenient ones. Thus, imine 1 was
reacted with different isocyanide (2a–d) and acid (3a–g)
components (Table 2). The dr of the products (4–15) was deter-
mined by a 1H NMR analysis of the crude mixture. However, in
most cases chromatographic purification allowed the separation
of the two diastereoisomers, the major a and the minor b.
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Scheme 1: Post-Ugi transformation on compound 10a.
Scheme 2: Post-Ugi cyclization on compound 15a.
Most of the products were obtained in acceptable yields, while
the dr proved to be more dependent on varying the different
components of the reaction. An exchange of the acid TFA with
formic acid (Table 2, entries 2, 4, 6 and 7) resulted in a decrease
of the dr. This may be caused by a minor stereofacial differenti-
ation of the intermediate carboxylate iminium ion during the
nucleophilic addition of the isocyanide. Isocyanide 2b (Table 2,
entry 3 and entry 4), formally derived from glycine, afforded
satisfactory results, thus letting us foresee the application of this
approach to isocyanides prepared from natural amino acids. If
compared with tert-butylisocyanide (2a), benzylisocyanide (2c)
(Table 2, entries 5, 6 and 13) seems to be less effective in terms
of an acceptable dr, while the yields were still good. Of interest
was also the product 10, derived from a reaction of isocyanide
2d (Table 2, entry 7), since it can be easily converted into the
correspondent primary amide derivative (vide infra).
To explore potential applications of the Ugi reaction products in
the field of peptidomimetics, we also tested the reaction of
ketimine 1 in the presence of different N-Boc-protected amino
acids as acid components. The use of L-amino acids 3c and 3d
(Table 2, entry 8 and entry 9) afforded the desired products with
moderate yields. The best result in terms of de (54%) was
achieved with the more hindered proline. The reaction of the
glycine derivative 3f produced a complex inseparable mixture
of products (Table 2, entry 11). When N-Boc-D-Pro was used as
the acid component (Table 2, entry 10) a high 96:4 dr was
measured despite a low yield (18%). This outcome suggests a
matching/mismatching effect between the chirality of ketimine
1 and that of the D-Pro or L-Pro reagent, respectively. Satisfac-
tory yields were also achieved with mono-ethyl fumarate as the
acid component (Table 2, entry 12 and entry 13). The obtained
products 14 and 15 can be further elaborated to yield more com-
plex structures (vide infra).
Next, selected post-Ugi transformations were investigated in
order to better evaluate the synthetic versatility of the Ugi
adducts. Compound 10a was easily converted to the primary
amide 16 and then to the known amino amide 17 [16], thus
establishing the possible subsequent functionalization of both
the primary amine and the isonitrile-derived primary carbox-
amide functional groups (Scheme 1). Also, this chemical corre-
lation of the major diastereoisomer 10a allowed us to further
confirm the prevailing S-configuration at the tetrasubstituted
stereocenter C3 of the Ugi products.
Compound 15a was submitted to a post-Ugi cyclization, namely
an intramolecular aza-Michael [24] reaction, which afforded
compound 18 bearing the privileged spiro-diketopiperazine
scaffold (Scheme 2). Spiro-diketopiperazines are present in
many natural products [38-40] and have recently received much
attention as pharmacologically active peptidomimetics [41-43].
The reaction proceeded smoothly in methanol under reflux in
the presence of excess TEA to give the product 18 by a regiose-
lective six-exo-trig cyclization.
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Conclusion
We have developed a novel approach to the synthesis of opti-
cally active 3,3-disubstituted 3-aminooxindoles by means of a
three-component Ugi reaction. A number of compounds could
be smoothly obtained in satisfactory yields (up to 77%) with
various levels of diastereoselectivity (up to 96:4 dr). The syn-
thetic versatility of the Ugi adducts was demonstrated by appli-
cations of post-Ugi transformations. Importantly, this repre-
sents the first example where an isocyanide-based multicompo-
nent reaction has been applied to an isatin-derived ketimine,
thus highlighting the promising reactivity of this derivative as a
precursor of chiral 3,3-disubstituted 3-aminooxindoles.
Supporting Information
Supporting information features the experimental section,
crystallographic data, general methods and copies of NMR
spectra (1H and 13C) for all new compounds.
Supporting Information File 1
Experimental section and crystallographic data.
[http://www.beilstein-journals.org/bjoc/content/
supplementary/1860-5397-10-141-S1.pdf]
Supporting Information File 2





1. Singh, G. S.; Desta, Z. Y. Chem. Rev. 2012, 112, 6104–6155.
doi:10.1021/cr300135y
2. Hanhan, N. V.; Sahin, A. H.; Chang, T. W.; Fettinger, J. C.; Franz, A. K.
Angew. Chem., Int. Ed. 2010, 49, 744–747.
doi:10.1002/anie.200904393
3. Thakur, P. B.; Sirisha, K.; Sarma, A. V. S.; Meshram, H. M.
Tetrahedron Lett. 2014, 55, 2459–2462.
doi:10.1016/j.tetlet.2014.03.008
4. Ding, K.; Lu, Y.; Nikolovska-Coleska, Z.; Qiu, S.; Ding, Y.; Gao, W.;
Stuckey, J.; Krajewski, K.; Roller, P. P.; Tomita, Y.; Parrish, D. A.;
Deschamps, J. R.; Wang, S. J. Am. Chem. Soc. 2005, 127,
10130–10131. doi:10.1021/ja051147z
5. Blakeney, J. S.; Reid, R. C.; Le, G. T.; Fairlie, D. P. Chem. Rev. 2007,
107, 2960–3041. doi:10.1021/cr050984g
6. Sato, S.; Shibuya, M.; Kanoh, N.; Iwabuchi, Y. J. Org. Chem. 2009, 74,
7522–7524. doi:10.1021/jo901352u
7. Decaux, G.; Soupart, A.; Vassart, G. Lancet 2008, 371, 1624–1632.
doi:10.1016/S0140-6736(08)60695-9
8. Shimazaki, T.; Iijima, M.; Chaki, S. Eur. J. Pharmacol. 2006, 543,
63–67. doi:10.1016/j.ejphar.2006.06.032
9. Crosignani, S.; Jorand-Lebrun, C.; Page, P.; Campbell, G.;
Colovray, V.; Missotten, M.; Humbert, Y.; Cleva, C.; Arrighi, J.-F.;
Gaudet, M.; Johnson, Z.; Ferro, P.; Chollet, A. ACS Med. Chem. Lett.
2011, 2, 644–649. doi:10.1021/ml2001196
10. Yeung, B. K. S.; Zou, B.; Rottmann, M.; Lakshminarayana, S. B.;
Ang, S. H.; Leong, S. Y.; Tan, J.; Wong, J.; Keller-Maerki, S.;
Fischli, C.; Goh, A.; Schmitt, E. K.; Krastel, P.; Francotte, E.; Kuhen, K.;
Plouffe, D.; Henson, K.; Wagner, T.; Winzeler, E. A.; Petersen, F.;
Brun, R.; Dartois, V.; Diagana, T. T.; Keller, T. H. J. Med. Chem. 2010,
53, 5155–5164. doi:10.1021/jm100410f
11. Rottmann, M.; McNamara, C.; Yeung, B. K. S.; Lee, M. C. S.; Zhou, B.;
Russell, B.; Seitz, P.; Plouffe, D. M.; Dharia, N. V.; Tan, J.;
Cohen, S. B.; Spencer, K. R.; Gonzalez-Paez, G. E.;
Lakshminarayana, S. B.; Goh, A.; Suwanarusk, R.; Jegla, T.;
Schmitt, E. K.; Beck, H.-P.; Brun, R.; Nosten, F.; Renia, L.; Dartois, V.;
Keller, T. H.; Fidock, D. A.; Winzeler, E. A.; Diagana, T. T. Science
2010, 329, 1175–1180. doi:10.1126/science.1193225
12. Zhang, H.; Zhang, S.-J.; Zhou, Q.-Q.; Dong, L.; Chen, Y.-C.
Beilstein J. Org. Chem. 2012, 8, 1241–1245. doi:10.3762/bjoc.8.139
13. Yan, W.; Wang, D.; Feng, J.; Li, P.; Zhao, D.; Wang, R. Org. Lett. 2012,
14, 2512–2513. doi:10.1021/ol3007953
14. Zhang, T.; Cheng, L.; Liu, L.; Wang, D.; Chen, Y.-J.
Tetrahedron: Asymmetry 2010, 21, 2800–2806.
doi:10.1016/j.tetasy.2010.11.002
15. Qian, Z.-Q.; Zhou, F.; Du, T.-P.; Wang, B.-L.; Ding, M.; Zhao, X.-L.;
Zhou, J. Chem. Commun. 2009, 6753–6755. doi:10.1039/b915257a
16. Sacchetti, A.; Silvani, A.; Gatti, F. G.; Lesma, G.; Pilati, T.; Trucchi, B.
Org. Biomol. Chem. 2011, 9, 5515–5522. doi:10.1039/c1ob05532a
17. Lesma, G.; Landoni, N.; Pilati, T.; Sacchetti, A.; Silvani, A.
J. Org. Chem. 2009, 74, 4537–4541. doi:10.1021/jo900623c
18. Lesma, G.; Landoni, N.; Sacchetti, A.; Silvani, A. Tetrahedron 2010,
66, 4474–4478. doi:10.1016/j.tet.2010.04.077
19. Baroni, M.; Lesma, G.; Puleio, L.; Sacchetti, A.; Silvani, A.; Zanchet, M.
Synthesis 2010, 4075–4081. doi:10.1055/s-0030-1258289
20. van Berkel, S. S.; Bögels, B. G. M.; Wijdeven, M. A.; Westermann, B.;
Rutjes, F. P. J. T. Eur. J. Org. Chem. 2012, 3543–3559.
doi:10.1002/ejoc.201200030
21. Dömling, A.; Wang, W.; Wang, K. Chem. Rev. 2012, 112, 3083–3135.
doi:10.1021/cr100233r
22. Dömling, A.; Ugi, I. Angew. Chem., Int. Ed. 2000, 39, 3168–3210.
doi:10.1002/1521-3773(20000915)39:18<3168::AID-ANIE3168>3.0.CO
;2-U
23. Zou, Y.; Hu, Y.; Liu, H.; Shi, D. ACS Comb. Sci. 2012, 14, 38–43.
doi:10.1021/co200128k
24. Santra, S.; Andreana, P. R. J. Org. Chem. 2011, 76, 2261–2264.
doi:10.1021/jo102305q
25. Nunez-Villanueva, D.; Angeles Bonache, M.; Infantes, L.;
Garcia-Lopez, M. T.; Martin-Martinez, M.; Gonzalez-Muniz, R.
J. Org. Chem. 2011, 76, 6592–6603. doi:10.1021/jo200894d
26. Zhu, D.; Chen, R.; Liang, H.; Li, S.; Pan, L.; Chen, X. Synlett 2010,
897–900. doi:10.1055/s-0029-1219533
27. Gulevich, A. V.; Shevchenko, N. E.; Balenkova, E. S.;
Röschenthaler, G.-V.; Nenajdenko, V. G. Tetrahedron 2008, 64,
11706–11712. doi:10.1016/j.tet.2008.10.004
28. Nenajdenko, V. G.; Gulevich, A. V.; Balenkova, E. S. Tetrahedron
2006, 62, 5922–5930. doi:10.1016/j.tet.2006.04.021
29. Hashimoto, T.; Kimura, H.; Kawamata, Y.; Maruoka, K.
Angew. Chem., Int. Ed. 2012, 51, 7279–7281.
doi:10.1002/anie.201201905
Beilstein J. Org. Chem. 2014, 10, 1383–1389.
1389
30. Yue, T.; Wang, M.-X.; Wang, D.-X.; Masson, G.; Zhu, J.
Angew. Chem., Int. Ed. 2009, 48, 6717–6721.
doi:10.1002/anie.200902385
31. Ram, D. J.; Yus, M. Angew. Chem., Int. Ed. 2005, 44, 1602–1634.
doi:10.1002/anie.200460548
32. Zou, D.; Xia, L.; Pan, L.; Li, S.; Chen, R.; Mou, Y.; Chen, X.
J. Org. Chem. 2012, 77, 1386–1395. doi:10.1021/jo2021967
33. Basso, A.; Banfi, L.; Riva, R.; Guanti, G. J. Org. Chem. 2005, 70,
575–579. doi:10.1021/jo048389m
34. Dyker, G.; Breitenstein, K.; Henkel, G. Tetrahedron: Asymmetry 2002,
13, 1929–1936. doi:10.1016/S0957-4166(02)00530-X




36. Ross, G. F.; Herdtweck, E.; Ugi, I. Tetrahedron 2002, 58, 6127–6133.
doi:10.1016/S0040-4020(02)00484-2
37. ORTEP-3 for Windows; Farrugia, L. J.: University of Glasgow,
Scotland, 1997.
38. Afiyatullov, S. S.; Zhuravleva, O. I.; Chaikina, E. L.; Anisimov, M. M.
Chem. Nat. Compd. 2012, 48, 95–98. doi:10.1007/s10600-012-0166-8
39. Gao, H.; Liu, W.; Zhu, T.; Mo, X.; Mándi, A.; Kurtán, T.; Li, J.; Ai, J.;
Gu, Q.; Li, D. Org. Biomol. Chem. 2012, 10, 9501–9506.
doi:10.1039/c2ob26757h
40. Wang, F.; Fang, Y.; Zhu, T.; Zhang, M.; Lin, A.; Gu, Q.; Zhu, W.
Tetrahedron 2008, 64, 7986–7991. doi:10.1016/j.tet.2008.06.013
41. Fytas, C.; Zoidis, G.; Tzoutzas, N.; Taylor, M. C.; Fytas, G.; Kelly, J. M.
J. Med. Chem. 2011, 54, 5250–5254. doi:10.1021/jm200217m
42. Watts, K. R.; Ratnam, J.; Ang, K.-H.; Tenney, K.; Compton, J. E.;
McKerrow, J.; Crews, P. Bioorg. Med. Chem. 2010, 18, 2566–2574.
doi:10.1016/j.bmc.2010.02.034
43. Gomez-Monterrey, I.; Campiglia, P.; Carotenuto, A.; Stiuso, P.;
Bertamino, A.; Sala, M.; Aquino, C.; Grieco, P.; Morello, S.; Pinto, A.;
Ianelli, P.; Novellino, E. J. Med. Chem. 2008, 51, 2924–2932.
doi:10.1021/jm7013056
License and Terms
This is an Open Access article under the terms of the
Creative Commons Attribution License
(http://creativecommons.org/licenses/by/2.0), which
permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
The license is subject to the Beilstein Journal of Organic
Chemistry terms and conditions:
(http://www.beilstein-journals.org/bjoc)
The definitive version of this article is the electronic one
which can be found at:
doi:10.3762/bjoc.10.141
